Medidata is a technology company that builds cloud-based software for clinical trials. Its flagship platform, Medidata Rave, is one of the most widely used systems in the pharmaceutical and life sciences industry for capturing, managing, and analyzing the data generated during drug and medical device studies. Medidata operates as a brand under Dassault Systèmes, the French technology company that acquired it in 2019.
What Medidata Does
At its core, Medidata provides the digital infrastructure that pharmaceutical companies, biotech firms, and contract research organizations use to run clinical trials. Before software like Medidata existed, much of the data collected during trials (patient vitals, lab results, adverse events, dosing records) was recorded on paper forms and manually entered into databases. Medidata’s tools replace that process with electronic data capture, real-time monitoring, and automated quality checks.
The company’s software covers the full lifecycle of a clinical trial: designing the study protocol, enrolling patients, collecting consent forms electronically, capturing data from research sites around the world, flagging data inconsistencies, and locking the final dataset for regulatory submission. All of this runs on a single cloud platform, which means sponsor companies and research sites access it through a web browser rather than installing software locally.
The Rave EDC Platform
Medidata Rave EDC (electronic data capture) is the company’s cornerstone product. It handles the capture, management, cleaning, and reporting of trial data so that sites, study teams, and regulators can trust the results. Rave EDC also serves as the hub that pulls in data from other sources, including electronic consent forms, patient-reported outcomes, randomization systems, and medical imaging.
One of Rave EDC’s distinguishing features is its ability to handle protocol amendments (changes to the study design that happen mid-trial) without any system downtime. Study teams can deploy changes to thousands of patients in hours rather than months. The platform also uses AI to automate repetitive configuration tasks during study setup, which shortens the time between protocol finalization and the first patient visit.
For simpler studies, Medidata offers Rave Lite, a scaled-down version of the platform designed for early-phase (Phase I), post-market (Phase IV), and medical device studies. Rave Lite covers essential data capture at a lower cost with faster study builds.
How It Fits Into Clinical Trials
A modern clinical trial generates enormous amounts of data across dozens or even hundreds of research sites worldwide. Medidata’s platform connects those sites into a single system where sponsor companies can monitor workflows, track site performance in real time, and extract full datasets at any point. Data flows from Rave EDC into a centralized oversight layer called Clinical Data Studio, which supports reconciliation, review, and monitoring.
The platform also addresses a long-standing pain point for research sites: duplicate data entry. Through a feature called Rave Companion, sites can automatically populate EDC forms with data pulled directly from electronic health records, reducing the manual burden on clinicians and cutting down on transcription errors.
On the patient side, Medidata unifies enrollment, consent, engagement, adherence tracking, and retention tools in one system. This matters because patient dropout is one of the biggest threats to trial timelines and costs. Keeping patients engaged through a consistent digital experience helps sponsors avoid the delays that come with re-recruiting.
Who Owns Medidata
Medidata Solutions was originally a publicly traded company on the NASDAQ under the ticker MDSO. In 2019, Dassault Systèmes completed its acquisition of Medidata, making it a core brand within Dassault’s 3DEXPERIENCE platform. After the acquisition, life sciences became Dassault Systèmes’ second-largest business segment after transportation and mobility. Medidata continues to operate under its own name, but its technology now ties into Dassault’s broader vision of “virtual twin” experiences, which use digital models to simulate biological and chemical processes.
Careers and Certification
If you’re searching for “what is Medidata” because you’ve seen it listed as a required skill on a job posting, you’re likely looking at roles in clinical data management, clinical trial operations, or study building. Clinical data managers, study builders, and clinical operations professionals are the primary users of the Rave platform.
Medidata offers a formal certification program for professionals who configure and manage studies in Rave EDC. The Rave EDC Certified Study Builder program provides a guided learning path that includes instructor-led training, a core skills exam, and an applied skills assessment designed to validate day-to-day proficiencies. A re-certification path lets professionals refresh their credentials without retaking the full program. Holding a Medidata certification signals to employers that you can independently build and manage studies on the platform, which is a practical requirement at many clinical research organizations and pharmaceutical companies.
For professionals entering the clinical research field, familiarity with Medidata Rave is one of the more marketable technical skills. The platform’s widespread adoption means that experience with it transfers across employers, whether you’re working at a large pharma company, a biotech startup, or a contract research organization.